How Muscle Fatigue Impacts Ms Patients' Brain Health

can muscle fatigue cause new plaque lesion for ms patients

Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord and can also impact the optic nerves. The disease causes damage to the myelin sheath, the protective material covering the nerves in the brain and spinal cord. This damage results in the development of lesions, also known as plaques or scars, which interfere with nerve stimulation and body movement. While fatigue is a well-known symptom of MS, with around 65% of patients experiencing it, the link between muscle fatigue and new plaque lesions is unclear. This paragraph will explore whether there is a connection between muscle fatigue and the development of new plaque lesions in MS patients.

Characteristics Values
Definition of Multiple sclerosis (MS) An autoimmune condition affecting the brain and spinal cord
Prevalence Over 2.5 million worldwide, including 400,000 in the US and 1 million adults in the US
Symptoms Fatigue, numbness, abnormal sensations, loss of vision, balance, bowel or bladder control, depression, difficulty walking or standing, paralysis, spasticity, muscle spasms, tremors, speech problems
Lesions Areas of damage in the brain or spinal cord, also called plaques or scars; detected by MRI scans
Diagnosis Based on signs, symptoms, medical imaging (MRI), laboratory testing, and neurological exams; McDonald criteria are commonly used
Treatment Medications, steroids, plasma exchange, precision medicine tools, disease-modifying treatments, antiseizure medications, antispasmodic medications, deep brain stimulation, assistive mobility devices, clinical trials
Fatigue in MS Most commonly reported and debilitating symptom, potentially related to endocrine and hormonal factors, restless legs syndrome (RLS)
Alternative treatments Dietary supplementation, vitamin D, yoga, herbal medicine, hyperbaric oxygen therapy, acupuncture, mindfulness

cyvigor

MS is an autoimmune condition that affects the brain and spinal cord

Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord (central nervous system). It is caused by damage to the myelin sheath, a protective covering that surrounds nerve cells. Myelin sheath damage interrupts messages (signals) that your nerves send throughout your body to perform functions like vision, sensation, and movement. This damage can occur in the brain, spinal cord, and nerves that supply the eyes.

MS is a chronic and incurable disorder that affects women more often than men. It is most commonly diagnosed between the ages of 20 and 40, but it can occur at any age. The exact cause of MS is unknown, but it is believed to be caused by a combination of genetic, environmental, and viral factors. People with a family history of MS or those living in certain parts of the world are at a slightly higher risk of developing the condition.

The symptoms of MS vary from person to person and can include numbness, abnormal sensations, blurred vision, muscle spasms, and fatigue. Fatigue is one of the most common symptoms, affecting about 65% of people with MS. It is often described as a decline in physical performance over time and can be disabling for some. Other symptoms include autonomic, visual, motor, and sensory problems, depending on the location of the lesions within the nervous system.

MS is typically diagnosed based on presenting signs and symptoms, medical imaging, and laboratory testing. The McDonald criteria, which focus on clinical, laboratory, and radiologic evidence of lesions at different times and areas, are commonly used for diagnosis. There is no cure for MS, but treatments are available to help manage symptoms and slow the disease's progression. These include medications, physical therapy, speech therapy, occupational therapy, and assistive devices.

cyvigor

Fatigue is a common symptom of MS, with 65% of patients experiencing it

Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord. The name "multiple sclerosis" refers to the numerous glial scars (or sclerae, plaques, or lesions) that develop on the brain and spinal cord. These lesions can affect any part of the central nervous system, so a person with MS can experience a wide range of neurological symptoms.

Fatigue is one of the most common symptoms of MS, with 65% of people with MS experiencing it. It is not just ordinary tiredness, but an overwhelming sense of tiredness with no obvious cause. For 15–40% of people with MS, fatigue is their most disabling symptom. Fatigue in MS patients has been linked to a decline in physical performance over time, or fatigability. However, the limited correlation between the two suggests they are distinct and warrant independent assessment in clinical studies.

The early signs of MS vary from person to person and can be vague, such as numbness and tingling. Other common symptoms include problems with vision, balance, dizziness, muscle stiffness, spasms, and tremors. The specific symptoms depend on the locations of the lesions within the nervous system.

There is no single diagnostic tool for MS, but a combination of physical and neurological exams, medical imaging, and laboratory testing is used. Gadolinium, a contrast agent, can be used to highlight active plaques and demonstrate the existence of historical lesions. Cerebrospinal fluid obtained from a lumbar puncture can also provide evidence of chronic inflammation in the central nervous system.

cyvigor

MS lesions can develop anywhere in the central nervous system

Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord (central nervous system). MS lesions can develop anywhere in the central nervous system. These lesions are areas of damage in the brain or spinal cord, sometimes called plaques or scars, and occur when the immune system attacks the myelin sheath around nerves, causing inflammation and scarring (sclerosis). This damage impedes the passage of messages between nerve cells, leading to the development of MS symptoms.

MS lesions can be detected using MRI scans, which can differentiate between active and non-active lesions. Active lesions appear as white patches when a contrast fluid containing gadolinium is injected, highlighting areas of inflammation. If the lesion does not light up, it is likely an older, inactive lesion. The presence, distribution, and type of lesions seen on MRI scans are important for neurologists in diagnosing MS and forming a treatment plan.

The specific symptoms of MS depend on the locations of the lesions within the nervous system. Lesions can cause a wide range of neurological signs and symptoms, including fatigue, autonomic, visual, motor, and sensory problems. For example, lesions affecting the limbs can lead to loss of sensitivity, tingling, numbness, motor weakness, or pain. Lesions in the brain can result in blurred vision, pronounced reflexes, muscle spasms, difficulty with coordination or balance, and speech or swallowing difficulties.

While there is no cure for MS, treatment options are available to help manage symptoms and slow disease progression. These include medications such as antiseizure or antispasmodic drugs, deep brain stimulation, plasma exchange, and assistive mobility devices. Physical therapy can also help strengthen muscles, improve coordination, and enhance mobility.

cyvigor

Lesions are areas of damage in the brain or spinal cord, also called plaques or scarring

Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord. MS lesions can affect any part of the central nervous system, and people with MS can exhibit almost any neurological signs or symptoms. Lesions are areas of damage in the brain or spinal cord, also called plaques or scarring. They occur when the immune system attacks the myelin sheath around nerves, causing inflammation and scarring (sclerosis).

On an imaging test like an MRI scan, evidence of myelin damage can be found. Healthcare providers may refer to this damage as a scar, lesion, or plaque. Messages between nerve cells are disrupted where there is myelin damage, leading to the development of MS symptoms. The size and position of a lesion on a scan do not always relate to the symptoms experienced by the MS patient. However, neurologists may use regular scans to determine how active an MS patient's disease is and how they may be affected.

Lesions can be caused by other diseases such as migraines, strokes, and infections, or they can develop with age. They can sometimes be detected before the patient experiences any symptoms. Brain lesions can happen with any condition or circumstance that can damage the brain, including brain tumours, congenital disorders, metabolic disorders, degenerative brain diseases, immune and inflammatory conditions, infections, and genetic conditions.

Lesions can sometimes heal or get smaller over time, but other lesions do not heal and tend to grow slowly. These are known as chronic active lesions or smouldering lesions, and they are thought to contribute to disease progression and worsening symptoms in MS.

cyvigor

An MRI scan can detect MS lesions and differentiate between active and non-active lesions

Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord. MS lesions can develop anywhere in the central nervous system, and patients can exhibit almost any neurological signs or symptoms. Fatigue is one of the most common symptoms of MS, with 65% of patients experiencing it and 15-40% reporting it as their most disabling symptom.

MRI scans are an excellent resource for people with MS, as they provide a safe, non-invasive way to obtain detailed images of the brain and spinal cord without radiation exposure. MRI scans can be used to detect MS and assess disease activity in all MS disease types. When the myelin sheath is damaged in MS, water accumulates in that area, and these water-rich areas of damage, called lesions, are visible on MRI scans as spots that are brighter or darker than the surrounding area.

There are several types of MRI scans that can be used to detect specific types of MS lesions. Active and inactive lesions can be distinguished on MRIs using a technique called gadolinium enhancement. Gadolinium is a contrast agent injected into the patient's bloodstream before the scan. Normally, a protective wall called the blood-brain barrier stops the contrast agent from entering the brain and spinal cord. However, active inflammation in a lesion causes this barrier to become leaky, resulting in a bright spot at that lesion as the contrast agent leaks past. These areas of active inflammation are called enhancing lesions. Inactive, older lesions will not be detected by this technique. T1-weighted scans without gadolinium can reveal persistent lesions, which show up as dark areas or "black holes" that indicate permanent nerve damage. T2-weighted scans are used to image the overall lesion load, both old and new lesions, and to highlight areas of demyelination, which appear as bright white spots.

While almost all people with MS will have evidence of brain lesions on MRI, not all people with brain lesions have MS. Therefore, an MRI report must be carefully reviewed by a healthcare provider, considering the patient's broader context. An MRI alone cannot assess a patient's overall health and must be studied with the patient in mind.

Frequently asked questions

Multiple sclerosis (MS) is an autoimmune condition and a neurological disease that affects the brain and spinal cord. It can also affect the optic nerves.

Lesions in MS are areas of damage in the brain or spinal cord. They occur when the immune system attacks the myelin sheath around nerves, causing inflammation and scarring (also known as sclerosis or plaques).

Fatigue is one of the most common symptoms of MS, affecting roughly 65% of patients. However, there is no direct link between muscle fatigue and new plaque lesions. Lesions develop due to inflammation and scarring caused by the immune system attacking the myelin sheath. Medications can help reduce relapses and the development of new lesions, as well as slow the progression of the disease. Evidence suggests that vitamin D supplementation does not provide benefits for MS patients in terms of relapse recurrence or the development of new lesions.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment